Fount Bio is applying proprietary advances in glycopolymer research to become the world’s first platform for building a long-lasting hyaluronic acid network within the skin via topical application. Fount’s Flī-HA™ technology overcomes both the delivery and biostability challenges of current forms of HA, that until now, have prevented the development of products that fully unleash HA’s benefits without the need for invasive injections.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Somerville, Massachusetts 02143, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.fountbio.com/
- HQ
- Somerville, Massachusetts
Fount Bio, Inc. Questions
Fount Bio, Inc.'s website is https://www.fountbio.com/
Fount Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/fount-bio-inc
Fount Bio, Inc. has
10 employees.
View email and phone details for 10
employees at Fount Bio, Inc..
Fount Bio, Inc.'s industry is
Pharmaceutical Manufacturing
Fount Bio, Inc.'s top competitors are
Takeda,
Cage Bio Inc.,
Morningside,
Wyss Institute At Harvard University,
Yourbio Health,
Loop Medical,
Abbvie,
Nomic Bio,
I2o Therapeutics,
Intellia Therapeutics, Inc..
Fount Bio, Inc.'s categories are Pharmaceutical Manufacturing
Fount Bio, Inc.'s founding year is 2019
